In combination with the fact that we only observed an association between acrylamide and endometrial cancer risk in women with at least one copy of GSTM1, this could, in line with the results for the CYP2E1 SNPS, suggest that acrylamide itself is the causative compound in endometrial carcinogenesis. The gene discussed is GSTM1; the disease is endometrial cancer.